emission tomography

Using positron emission tomography (PET) to track tracer doses of methamphetamine in humans’ brains, scientists at Brookhaven Lab find that the addictive and long-lasting effects of this increasingly prevalent drug can be explained in part by its pharmacokinetics — the rate at which it enters and clears the brain, and its distribution.

SNM congratulates the Academy of Molecular Imaging, the American College of Radiology and ACR Imaging Network on the recent release of significant data from the National Oncologic PET Registry that dramatically illustrate the effectiveness of positron emission tomography in the diagnosis of cancer.

The recent release of data by the National Oncologic PET Registry showing that positron emission tomography produced scans revealing disease at a molecular level, which then caused physicians to change treatment plans for more than one-third of participating patients, has corroborated decades of nuclear medicine research.

Combined positron emission tomography and computed tomography imaging of lymphoma patients is a more effective method to evaluate response to radiation therapy, and may help patients avoid unnecessary follow-up treatments, a new study suggests.

The fused imaging results in greater accuracy when evaluating treatment results.

Researchers involved in a large, multi-institutional study using positron emission tomography imaging with the radiotracer fluorodeoxyglucose were able to classify different types of dementia with very high rates of success, raising hopes that dementia diagnoses may one day be made at earlier stages.